Sector performance

as of 7:45 AM ET 04/24/2024

Loading...

Latest sector news

Humana's Q1 Adjusted Earnings Fall, Revenue Rises; 2024 Adjusted EPS Outlook Reaffirmed

7:30 AM ET 04/24/2024 - MT Newswires

07:30 AM EDT, 04/24/2024 (MT Newswires) -- Humana (HUM) reported Q1 adjusted earnings Wednesday of $7.23 per share, down from $9.38 a year earlier. More

Boston Scientific's Adjusted Q1 Earnings, Net Sales Rise; Q2, 2024 Outlook Issued, Shares Advance Pre-Bell 7:20 AM ET 04/24/2024 - MT Newswires
Leerink Partners Adjusts Quest Diagnostics Price Target to $141 From $135 7:18 AM ET 04/24/2024 - MT Newswires
Evercore ISI Adjusts Cardinal Health's Price Target to $110 From $118, Keeps In Line Rating 6:51 AM ET 04/24/2024 - MT Newswires
TD Cowen Adjusts Regeneron Pharmaceuticals' Price Target to $1,030 From $1,020, Keeps Buy Rating 6:46 AM ET 04/24/2024 - MT Newswires

Best and worst stocks in this sector

as of 7:45 AM ET 04/24/2024
Best-performing stocks
Symbol Name % change
SCLN Sciclone Pharmaceuticals,... 0.00%
ZLTQ Zeltiq Aesthetics, Inc. 0.00%
DSCI Derma Sciences, Inc. 0.00%
ETRM Null 0.00%
HH Hooper Holmes, Inc. 0.00%
KITE Kite Pharma, Inc. 0.00%
MATN Mateon Therapeutics, Inc. 0.00%
NDRM Neuroderm Ltd. - Ordinary... 0.00%
NWBO Northwest Biotherapeutics... 0.00%
OPXA Null 0.00%
Worst-performing stocks
Symbol Name % change
ADHD Alcobra Ltd –85.10%
BIOB Bio-rad Laboratories, Inc... –0.14%
DSCI Derma Sciences, Inc. 0.00%
ETRM Null 0.00%
HH Hooper Holmes, Inc. 0.00%
KITE Kite Pharma, Inc. 0.00%
MATN Mateon Therapeutics, Inc. 0.00%
NDRM Neuroderm Ltd. - Ordinary... 0.00%
NWBO Northwest Biotherapeutics... 0.00%
OPXA Null 0.00%